The UK hemostats, tissue sealants, and adhesion barriers market is expected to grow at a CAGR of around 2.8% during 2024-2033. This report on UK hemostats, tissue sealants, and adhesion barriers market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the UK hemostats, tissue sealants, and adhesion barriers market by segmenting the market based on product, application, and region. Also, detailed profiles of companies operating in the data center colocation market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
The hemostat market is growing owing to the associated safety benefits for patients during surgical procedures and faster post-operative recovery. Hemostatic drugs have a number of advantages, including faster wound healing and operative time, better management of anti-coagulated patients, and a shorter recovery time for patients. Moreover, any surgical operation that is conducted through small incisions rather than a huge hole is referred to as minimally invasive surgery. As the issues faced by the surgeons are growing rapidly, understanding the various surgical toolbox components that can aid in the technical performance of an operation has become increasingly crucial. Therefore, for surgeon, the need for smaller, less intrusive procedures, lower transfusion rates, and lower costs present greater challenges than ever before.
Market Restraints
The acceptance of hemostats, sealants, and adhesion barriers has been hampered by its high costs. There are several different surgical hemostatic agents on the market, each with its own composition and price. As a result, choosing the right hemostatic drugs can have an impact on clinical results and treatment costs. The current corporate world is characterized by rapid technological change, which might present challenges. The cost of adopting new technology is one potential downside of changing technology. Existing products or products in development may become obsolete or unmarketable as a result of the introduction of new technology or the acceptance of new industry standards. Additionally, in surgical operations, wound closure agents such as hemostats, sealants, and adhesion barriers are commonly utilized. The blood clotting phenomenon with hemostats is dependent on the patient’s compatibility with the product.
Market Opportunities
Several types of chronic diseases, such as cardiovascular diseases, cancer, and the occurrence of trauma and accidents, are on the rise in today’s healthcare environment. Obesity and physical inactivity are prominent risk factors for a variety of diseases, but they have received less attention as risk factors for multimorbidity. Additionally, the increase in the number of surgical procedures performed in the United Kingdom has boosted the market for hemostats, sealants, and adhesion barriers. As a result, there has been a concerted push to address the increased prevalence of bleeding issues during surgeries. In the United Kingdom, hikes in healthcare spending consistently surpass growth in GDP and overall government spending. In the United Kingdom, for instance, healthcare expenditure amounted for 10.3 percent of GDP in 2019. Behaviors and lifestyle factors such as smoking, diet, and physical activity, as well as wealth and income effects and prices, are known drivers of overall healthcare expenditure rise. There is evidence that demographic issues like population aging are linked to rising healthcare costs.
Industry Development
- In Nov 2023, Johnson & Johnson’s MedTech division, Ethicon, introduces Ethizia, a hemostatic sealing patch, obtaining European approval for its launch, marking a significant addition to their medical offerings in Europe.
UK E-bike Market Report Highlights:
- The hemostats segment dominated the UK hemostats, tissue sealants and adhesion barriers market by product with 58.1% in 2023. Hemostats are used to compress blood arteries and stop blood or other fluids from flowing. They are most commonly utilized to control bleeding during surgical procedures.
- Based on application, general surgery dominated segment held the largest market share of 30.1% in 2023 and is anticipated to dominate the market over the forecast period. Hemostats were developed to prevent hemorrhage in general surgery by locking tiny blood arteries. In general surgery, surgeons and other health care providers use many techniques to stop bleeding.
- London generated the highest revenue estimating around 15.6% of the total market. Growth in this market is driven by increasing number of surgeries and transplants performed coupled with rising incidence of sports-related injuries and ailments in proliferating the market demand for hemostats, tissue sealants and adhesion barriers.
Historical & Forecast Period
Base Year: 2023
Historical Period: 2019-2023
Forecast Period: 2024-2033
Report’s Unit: US$
UK Hemostats, Tissue Sealants, and Adhesion Barriers Market Segmentation
Market by Product
- Hemostats
- Oxidized Regenerated Cellulose Based
- Combination Based
- Gelatin Based
- Collagen Based
- Thrombin Based
- Tissue Sealants
- Fibrin Sealants
- Synthetic Sealants
- Adhesion Barrier Products
Market by Application
- General Surgery
- Neurological Surgery
- Orthopaedic Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynaecological Surgery
- Others
Market by Region
- London
- South East
- North West
- South West
- East England
- Rest of UK
List of Mentioned Companies
- Advanced Medical Solutions Group PLC
- Baxter International Inc.
- Braun Melsungen AG
- BD Company LLC
- Corza Health Inc.
- CryoLife, Inc.
- GELITA Medical GmbH
- Johnson & Johnson
- Medtronic PLC.
Report Coverage
| Report Feature | Details |
| Base Year | 2023 |
| Historical Period | 2019-2022 |
| Forecast Period | 2024-2033 |
| Units | US$ Million |
| Segments Covered | Product, Application, Region |
| Region Covered | London, South East, North West, South West, East England, Rest of UK |
| Companies Covered | Advanced Medical Solutions Group PLC, Baxter International Inc., B. Braun Melsungen AG, BD Company LLC, Corza Health Inc., CryoLife, Inc., GELITA Medical GmbH, Johnson & Johnson, Medtronic PLC. |
| Purchase Options | Single User License: US$ 2,999 Five User License: US$ 3,499 Corporate License: US$ 4,499 |
Research Methodology
During the course of the research study, we conducted extensive primary and secondary research. The research commenced with extensive exploration through secondary sources followed by primary research. With these research methods, we were able to estimate the market size, to identify the factors that promote the growth in this market as well as the factors that hamper the growth in the market.
Comprehensive primary and secondary methods helped us to identify the trends in the market and to project the opportunities that the key players may get during the forecast period. Apart from these approaches, various analytical and statistical approaches were also used during data extraction cleaning, and analysis.
Post-secondary & primary research, we conducted expert interviews to validate all the information we collected during the course of the study. So, a blend of these three-way approaches helped us in data triangulation and to provide an accurate market scenario in our report.
Key Questions Answered in the Report
- What will be the UK hemostats, tissue sealants, and adhesion barriers market size and the growth rate in the coming year?
- What are the main key factors driving the market?
- What are the key market trends impacting the growth of the market?
- What are the market opportunities and threats in the market?
- What industrial trends, drivers, and challenges are manipulating its growth?
- Which are trending factors influencing the market shares of the top regions across the globe?
- Who are the key market players in the industry?
- What is the impact of Covid19 on the current industry?
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
2.1. Europe Market in 2023
2.2. Impact of COVID-19
2.3. Growth Opportunities and Challenges
2.4. Key Industry Trends
3. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market Dynamics
3.1. Introduction
3.2. Market DROs
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Industry Trends
3.4. SWOT Analysis
3.5. Market Value Chain Analysis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Key Price Indicators
3.9. Ansoff Matrix
3.10. Government Laws and Industry Regulations
4. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market Analysis
4.1. Market Portraiture
4.2. Market Size (US$ Million, 2019-2023)
4.3. Market Forecast (US$ Million, 2024-2033)
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market by Product (US$ Million, 2019-2033)
5.1. Introduction
5.2. Hemostats
5.2.1. Oxidized Regenerated Cellulose Based
5.2.2. Combination Based
5.2.3. Gelatin Based
5.2.4. Collagen Based
5.2.5. Thrombin Based
5.3. Tissue Sealants
5.3.1. Fibrin Sealants
5.3.2. Synthetic Sealants
5.4. Adhesion Barrier Products
5.5. Key Segment Investment Opportunity
6. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market by Application (US$ Million, 2019-2033)
6.1. Introduction
6.2. General Surgery
6.3. Neurological Surgery
6.4. Orthopaedic Surgery
6.5. Cardiovascular Surgery
6.6. Reconstructive Surgery
6.7. Gynaecological Surgery
6.8. Others
6.9. Key Segment Investment Opportunity
7. UK Hemostats, Tissue Sealants, and Adhesion Barriers Region (US$ Million, 2019-2033)
7.1. Introduction
7.2. Key Drivers and Takeaways
7.3. London
7.4. South East
7.5. North West
7.6. South West
7.7. East England
7.8. Rest of UK
8. Competitive Landscape
8.1. Competitive Dashboard
8.2. Key Industry Strategies Analysis
8.3. Recent Developments
8.4. Market Scenario
9. Company Profiles
9.1. Advanced Medical Solutions Group PLC
9.2. Baxter International Inc.
9.3. B. Braun Melsungen AG
9.4. BD Company LLC
9.5. Corza Health Inc.
9.6. CryoLife, Inc.
9.7. GELITA Medical GmbH
9.8. Johnson & Johnson
9.9. Medtronic PLC
- Description
-
The UK hemostats, tissue sealants, and adhesion barriers market is expected to grow at a CAGR of around 2.8% during 2024-2033. This report on UK hemostats, tissue sealants, and adhesion barriers market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the UK hemostats, tissue sealants, and adhesion barriers market by segmenting the market based on product, application, and region. Also, detailed profiles of companies operating in the data center colocation market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
The hemostat market is growing owing to the associated safety benefits for patients during surgical procedures and faster post-operative recovery. Hemostatic drugs have a number of advantages, including faster wound healing and operative time, better management of anti-coagulated patients, and a shorter recovery time for patients. Moreover, any surgical operation that is conducted through small incisions rather than a huge hole is referred to as minimally invasive surgery. As the issues faced by the surgeons are growing rapidly, understanding the various surgical toolbox components that can aid in the technical performance of an operation has become increasingly crucial. Therefore, for surgeon, the need for smaller, less intrusive procedures, lower transfusion rates, and lower costs present greater challenges than ever before.
Market Restraints
The acceptance of hemostats, sealants, and adhesion barriers has been hampered by its high costs. There are several different surgical hemostatic agents on the market, each with its own composition and price. As a result, choosing the right hemostatic drugs can have an impact on clinical results and treatment costs. The current corporate world is characterized by rapid technological change, which might present challenges. The cost of adopting new technology is one potential downside of changing technology. Existing products or products in development may become obsolete or unmarketable as a result of the introduction of new technology or the acceptance of new industry standards. Additionally, in surgical operations, wound closure agents such as hemostats, sealants, and adhesion barriers are commonly utilized. The blood clotting phenomenon with hemostats is dependent on the patient’s compatibility with the product.
Market Opportunities
Several types of chronic diseases, such as cardiovascular diseases, cancer, and the occurrence of trauma and accidents, are on the rise in today’s healthcare environment. Obesity and physical inactivity are prominent risk factors for a variety of diseases, but they have received less attention as risk factors for multimorbidity. Additionally, the increase in the number of surgical procedures performed in the United Kingdom has boosted the market for hemostats, sealants, and adhesion barriers. As a result, there has been a concerted push to address the increased prevalence of bleeding issues during surgeries. In the United Kingdom, hikes in healthcare spending consistently surpass growth in GDP and overall government spending. In the United Kingdom, for instance, healthcare expenditure amounted for 10.3 percent of GDP in 2019. Behaviors and lifestyle factors such as smoking, diet, and physical activity, as well as wealth and income effects and prices, are known drivers of overall healthcare expenditure rise. There is evidence that demographic issues like population aging are linked to rising healthcare costs.
Industry Development
- In Nov 2023, Johnson & Johnson’s MedTech division, Ethicon, introduces Ethizia, a hemostatic sealing patch, obtaining European approval for its launch, marking a significant addition to their medical offerings in Europe.
UK E-bike Market Report Highlights:
- The hemostats segment dominated the UK hemostats, tissue sealants and adhesion barriers market by product with 58.1% in 2023. Hemostats are used to compress blood arteries and stop blood or other fluids from flowing. They are most commonly utilized to control bleeding during surgical procedures.
- Based on application, general surgery dominated segment held the largest market share of 30.1% in 2023 and is anticipated to dominate the market over the forecast period. Hemostats were developed to prevent hemorrhage in general surgery by locking tiny blood arteries. In general surgery, surgeons and other health care providers use many techniques to stop bleeding.
- London generated the highest revenue estimating around 15.6% of the total market. Growth in this market is driven by increasing number of surgeries and transplants performed coupled with rising incidence of sports-related injuries and ailments in proliferating the market demand for hemostats, tissue sealants and adhesion barriers.
Historical & Forecast Period
Base Year: 2023
Historical Period: 2019-2023
Forecast Period: 2024-2033
Report’s Unit: US$
UK Hemostats, Tissue Sealants, and Adhesion Barriers Market Segmentation
Market by Product
- Hemostats
- Oxidized Regenerated Cellulose Based
- Combination Based
- Gelatin Based
- Collagen Based
- Thrombin Based
- Tissue Sealants
- Fibrin Sealants
- Synthetic Sealants
- Adhesion Barrier Products
Market by Application
- General Surgery
- Neurological Surgery
- Orthopaedic Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynaecological Surgery
- Others
Market by Region
- London
- South East
- North West
- South West
- East England
- Rest of UK
List of Mentioned Companies
- Advanced Medical Solutions Group PLC
- Baxter International Inc.
- Braun Melsungen AG
- BD Company LLC
- Corza Health Inc.
- CryoLife, Inc.
- GELITA Medical GmbH
- Johnson & Johnson
- Medtronic PLC.
Report Coverage
Report Feature Details Base Year 2023 Historical Period 2019-2022 Forecast Period 2024-2033 Units US$ Million Segments Covered Product, Application, Region Region Covered London, South East, North West, South West, East England, Rest of UK Companies Covered Advanced Medical Solutions Group PLC, Baxter International Inc., B. Braun Melsungen AG, BD Company LLC, Corza Health Inc., CryoLife, Inc., GELITA Medical GmbH, Johnson & Johnson, Medtronic PLC. Purchase Options Single User License: US$ 2,999
Five User License: US$ 3,499
Corporate License: US$ 4,499Research Methodology
During the course of the research study, we conducted extensive primary and secondary research. The research commenced with extensive exploration through secondary sources followed by primary research. With these research methods, we were able to estimate the market size, to identify the factors that promote the growth in this market as well as the factors that hamper the growth in the market.
Comprehensive primary and secondary methods helped us to identify the trends in the market and to project the opportunities that the key players may get during the forecast period. Apart from these approaches, various analytical and statistical approaches were also used during data extraction cleaning, and analysis.
Post-secondary & primary research, we conducted expert interviews to validate all the information we collected during the course of the study. So, a blend of these three-way approaches helped us in data triangulation and to provide an accurate market scenario in our report.Key Questions Answered in the Report
- What will be the UK hemostats, tissue sealants, and adhesion barriers market size and the growth rate in the coming year?
- What are the main key factors driving the market?
- What are the key market trends impacting the growth of the market?
- What are the market opportunities and threats in the market?
- What industrial trends, drivers, and challenges are manipulating its growth?
- Which are trending factors influencing the market shares of the top regions across the globe?
- Who are the key market players in the industry?
- What is the impact of Covid19 on the current industry?
- Table of Contents
-
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
2.1. Europe Market in 2023
2.2. Impact of COVID-19
2.3. Growth Opportunities and Challenges
2.4. Key Industry Trends
3. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market Dynamics
3.1. Introduction
3.2. Market DROs
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Industry Trends
3.4. SWOT Analysis
3.5. Market Value Chain Analysis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Key Price Indicators
3.9. Ansoff Matrix
3.10. Government Laws and Industry Regulations
4. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market Analysis
4.1. Market Portraiture
4.2. Market Size (US$ Million, 2019-2023)
4.3. Market Forecast (US$ Million, 2024-2033)
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market by Product (US$ Million, 2019-2033)
5.1. Introduction
5.2. Hemostats
5.2.1. Oxidized Regenerated Cellulose Based
5.2.2. Combination Based
5.2.3. Gelatin Based
5.2.4. Collagen Based
5.2.5. Thrombin Based
5.3. Tissue Sealants
5.3.1. Fibrin Sealants
5.3.2. Synthetic Sealants
5.4. Adhesion Barrier Products
5.5. Key Segment Investment Opportunity
6. UK Hemostats, Tissue Sealants, and Adhesion Barriers Market by Application (US$ Million, 2019-2033)
6.1. Introduction
6.2. General Surgery
6.3. Neurological Surgery
6.4. Orthopaedic Surgery
6.5. Cardiovascular Surgery
6.6. Reconstructive Surgery
6.7. Gynaecological Surgery
6.8. Others
6.9. Key Segment Investment Opportunity
7. UK Hemostats, Tissue Sealants, and Adhesion Barriers Region (US$ Million, 2019-2033)
7.1. Introduction
7.2. Key Drivers and Takeaways
7.3. London
7.4. South East
7.5. North West
7.6. South West
7.7. East England
7.8. Rest of UK
8. Competitive Landscape
8.1. Competitive Dashboard
8.2. Key Industry Strategies Analysis
8.3. Recent Developments
8.4. Market Scenario
9. Company Profiles
9.1. Advanced Medical Solutions Group PLC
9.2. Baxter International Inc.
9.3. B. Braun Melsungen AG
9.4. BD Company LLC
9.5. Corza Health Inc.
9.6. CryoLife, Inc.
9.7. GELITA Medical GmbH
9.8. Johnson & Johnson
9.9. Medtronic PLC